Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2013 Mar 1;11(3):275-280.

Cutaneous T-cell lymphoma in sub-Saharan Africa.

Author information

1
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle WA.
2
Department of Medicine, University of Washington, Seattle WA.
3
Uganda Cancer Institute, Kampala, Uganda.
4
Department of Medicine, Makere University, College of Health Sciences, Kampala, Uganda.
5
Department of Pathology, Makere University, College of Health Sciences, Kampala, Uganda.
6
Division of Hematopathology, Department of Laboratory Medicine, University of Washington, Seattle, WA.
7
Department of Dermatology, Mulago Hospital, Kampala, Uganda.
8
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA.
9
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle WA.
#
Contributed equally

Abstract

The incidence and economic burden of cancer in sub-Saharan Africa is increasing, and innovative strategies are needed to improve prevention and care in this population. This article uses a case of cutaneous T-cell lymphoma in Uganda to propose guidelines for the diagnosis and treatment of this disease in resource-limited settings. These guidelines were developed from the consensus opinion of specialists at the Uganda Cancer Institute and Fred Hutchinson Cancer Research Center as part of an established collaboration. Areas for future investigation that can improve the care of patients in this region are identified.

PMID:
23486453
PMCID:
PMC3865990
DOI:
10.6004/jnccn.2013.0038
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center